Therapeutic potentials of small molecular weight allosteric agonist of relaxin receptor
Alexander I. Agoulnik(Florida International University), Juan Marugán(National Institutes of Health), Noel Southall(National Institutes of Health), Irina U. Agoulnik(University of South Florida), Brian A. Ho(Florida International University), Elena Barnaeva(National Center for Advancing Translational Sciences), Mariluz Soula(Rockefeller University), Xin Hu, Zaohua Huang(Florida International University), Jingbo Xiao(National Center for Advancing Translational Sciences), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Courtney Myhr(Florida International University), Elena M. Kaftanovskaya(Florida International University)
Cited by 0
Related Papers
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
|Science Translational Medicine|2019|259